NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00931242,Study of Apremilast in Atopic or Contact Dermatitis,https://clinicaltrials.gov/study/NCT00931242,,COMPLETED,The objective of this study is to evaluate the efficacy of apremilast in patients with recalcitrant atopic or contact dermatitis.,YES,Atopic Dermatitis|Allergic Contact Dermatitis,DRUG: Apremilast,"Number of Patients Achieving an Improvement (Decrease) in IGA (Investigator Global Assessment) by Two or More Points, Improvement in IGA (Investigator Global Assessment) by two or more points on a five point scale, with 0 being no disease activity and 5 being maximum disease activity, at week 12, 12 weeks","Number of Patients Achieving 75% Reduction in Eczema Area and Severity Index (EASI) Score at Week 12 in Reference to Week 0, EASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, edema, lichenification, and excoriations/erosions are scored on a scale of 0 (none) to 3 (severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 to 6. The total qualitative score is multiplied by the degree of involvement for each anatomic region and then multiplied by a constant and summed to yield the EASI score., 12 weeks|Number of Patients Achieving 50% Reduction in Eczema Area and Severity Index (EASI) Score at Week 12 in Reference to Week 0, EASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, edema, lichenification, and excoriations/erosions are scored on a scale of 0 (none) to 3 (severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 to 6. The total qualitative score is multiplied by the degree of involvement for each anatomic region and then multiplied by a constant and summed to yield the EASI score., 12 weeks",,Tufts Medical Center,Celgene Corporation,ALL,"ADULT, OLDER_ADULT",PHASE2,10,OTHER,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,AD / CD|AP-ECZ-PI-0030,2009-06,2010-03,2010-03,2009-07-02,2010-10-28,2010-12-20,"Tufts Medical Center, Department of Dermatology, Boston, Massachusetts, 02111, United States",
